Neurotrope Alzheimer’s Phase 2 Trial Data Coming On Monday – Benzinga

April 28, 2017 by  
Filed under Alzheimers News

Sponsored By

Benzinga
Neurotrope Alzheimer's Phase 2 Trial Data Coming On Monday
Benzinga
Shares of Neurotrope Inc (NASDAQ: NTRP), a clinical-stage biopharmaceutical company that develops therapies for the treatment of Alzheimer's and neurodegenerative diseases, shot higher by more than 15 percent early Friday morning. Neurotrope …
Neurotrope Bioscience to Release Results From Phase 2 Clinical Trial in Moderate to Severe Alzheimer's Disease on …PR Newswire (press release)

all 5 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*